These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9517755)

  • 1. Methotrexate induced lymphoma?
    Bleyer WA
    J Rheumatol; 1998 Mar; 25(3):404-7. PubMed ID: 9517755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate].
    van Poppel PC; Fijnheer R; Haverman JF; Sinniqe HA
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2351-6. PubMed ID: 19024068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate's efficacy?
    Killeen OG; Gardner-Medwin JM
    Arch Dis Child; 2006 Jun; 91(6):537-8. PubMed ID: 16714734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reducing toxicity of methotrexate with folic acid].
    Harten P
    Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of methotrexate in childhood rheumatic diseases.
    Wallace CA
    Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE.
    Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y
    J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
    Whittle SL; Hughes RA
    Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
    Clarke LE; Junkins-Hopkins J; Seykora JT; Adler DJ; Elenitsas R
    J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis.
    Castaneda O; Nair MG
    J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review.
    Kennedy JW; Wong LK; Kalantarian B; Turner L; Hayes CW
    J Hand Surg Am; 2006 Sep; 31(7):1193-6. PubMed ID: 16945726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
    Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
    J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced pulmonary non-Hodgkin lymphoma.
    Mackie GC; Pohlen JM
    Clin Nucl Med; 2006 May; 31(5):272-4. PubMed ID: 16622335
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
    Ekochin LH; Manadan AM; Aggarwal R; Sequeira W; Block JA
    J Rheumatol; 2009 Sep; 36(9):2127. PubMed ID: 19738229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
    Glück T; Müller-Ladner U
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1901-4. PubMed ID: 17823884
    [No Abstract]   [Full Text] [Related]  

  • 15. Is methotrexate oncogenic in patients with rheumatoid arthritis?
    Kremer JM
    Semin Arthritis Rheum; 1997 Jun; 26(6):785-7. PubMed ID: 9213376
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate-associated lymphoproliferative disorder masquerading as interstitial lung disease.
    Jois RN; Gaffney K; Cane P; Nicholson AG; Wotherspoon AC
    Histopathology; 2007 Nov; 51(5):709-12. PubMed ID: 17927594
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate-associated lymphoproliferative disorder mimicking pyocyanic ecthyma gangrenosum in a patient with rheumatoid arthritis.
    Inuzuka K; Endo Y; Kato M; Fujisawa A; Tanioka M; Kabashima K; Tsukamoto H; Sonobe J; Bessho K; Miyachi Y
    Eur J Dermatol; 2013; 23(3):418-9. PubMed ID: 23783770
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistence of Epstein-Barr virus-associated lymphoproliferative disorder and marginal zone B-cell lymphoma of the thymus in a patient with rheumatoid arthritis treated with methotrexate.
    Fujimoto M; Yuba Y; Huang CL; Kobashi Y; Koyanagi I; Sakashita H; Haga H
    Histopathology; 2012 Dec; 61(6):1230-2. PubMed ID: 22958131
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate--the anchor drug--an introduction.
    Pincus T; Cronstein B; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S1-2. PubMed ID: 21044424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.